Key result
Compared to patients with cancer, patients with heart failure had a significantly lower probability of positive health status at their first palliative care consultation (adjusted RR 0.70).
Why the study?
How do unresolved symptoms and treatment gaps compare between patients with heart failure and patients with cancer presenting to community-based palliative care?
Cross-Sectional (n=1,031)
Yes
How do unresolved symptoms and treatment gaps compare between patients with heart failure and patients with cancer presenting to community-based palliative care?
Relative Risk: 0.7 (95% CI 0.55–0.9)
p-value: p=0.01
Heart failure patients presenting to palliative care have distinct needs compared to cancer patients, notably experiencing more severe dyspnea and dyspnea-related treatment gaps, highlighting the need for tailored palliative interventions.
Indicates poorer health status in heart failure at palliative referral; hypothesis-generating for disease-specific strategies.
BACKGROUND: As the role of palliative care (PC) has yet to be clearly defined in patients with heart failure (HF), such patients may face barriers regarding PC referral. In order to maximally meet the needs of HF patients, it is necessary to understand how they compare to the classic PC population: patients with cancer. OBJECTIVE: To characterize the unresolved symptom and treatment needs with which patients with HF and those with cancer present to PC. METHODS: We used data from the Palliative Care Research Registry (PCRR), a repository of quality improvement data from three community-based PC organizations. We abstracted first PC visit data from the PCRR for patients with primary diagnoses of HF or cancer seen between 2008 and 2012. We assessed the association of primary diagnosis (i.e., HF or cancer) on three outcomes: unresolved symptoms, treatment gaps, and a composite indicator of symptom control and quality of life. Analyses included descriptive statistics and multivariate Poisson regression. RESULTS: Our analytic sample comprised 334 patients with HF and 697 patients with cancer, the majority of whom were white and male. Compared to patients with cancer, patients with HF presented with fewer unresolved symptoms, both overall and at moderate/severe distress levels. Patients with HF more commonly reported moderately/severely distressful dyspnea (25% versus 18%, p=0.02), and more commonly experienced dyspnea-related treatment gaps (17% versus 8%, p<0.001). CONCLUSIONS: Patients with HF possess care needs that are squarely within the purview of PC. Future work is needed to delineate how PC referral policies should be refined to optimize PC access for patients with HF.
No takes yet. Share an insight, caveat, or question.
Kavalieratos et al. (2014) conducted a cross-sectional in Heart Failure and Cancer (n=1,031). Heart failure vs. Cancer was evaluated on Positive palliative care patient health status (PC-PHS) (RR 0.70, 95% CI 0.55-0.90, p=0.01). Compared to patients with cancer, patients with heart failure had a significantly lower probability of positive health status at their first palliative care consultation (adjusted RR 0.70).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: